Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (6): 590-595.DOI: 10.3969/j.issn.1673-8640.2021.06.003
Previous Articles Next Articles
HUANG Xiaofeng1, FAN Xueming2, YAO Tianyue1, YUAN Wenhua1, ZHAO Zhiyun1, SONG Yunxiao1()
Received:
2020-08-09
Online:
2021-06-30
Published:
2021-06-30
Contact:
SONG Yunxiao
CLC Number:
HUANG Xiaofeng, FAN Xueming, YAO Tianyue, YUAN Wenhua, ZHAO Zhiyun, SONG Yunxiao. Correlation between red cell distribution width and prostate cancer[J]. Laboratory Medicine, 2021, 36(6): 590-595.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.06.003
组别 | 例数 | 年龄/岁 | 体质量指数/ (kg/m2) | 糖尿病 | 高血压 | 吸烟史 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
是/例 | 否/例 | 是/例 | 否/例 | 是/例 | 否/例 | |||||||
前列腺癌组 | 497 | 73.03±9.55 | 23.06±2.91 | 47 | 450 | 89 | 408 | 155 | 342 | |||
对照组 | 519 | 72.98±6.63 | 22.95±3.26 | 55 | 464 | 97 | 422 | 176 | 343 | |||
统计值 | 0.099 | 0.605 | 0.366 | 0.104 | 0.858 | |||||||
P值 | 0.921 | 0.546 | 0.545 | 0.747 | 0.354 | |||||||
组别 | 饮酒史 | f-PSA/ (ng/mL) | t-PSA/ (ng/mL) | f-PSA/t-PSA 比值 | 白细胞/ (×109/ L) | 红细胞/ (×1012/ L) | ||||||
是/例 | 否/例 | |||||||||||
前列腺癌组 | 202 | 295 | 49.28±142.38 | 242.15±388.32 | 0.23±0.26 | 6.74±3.32 | 3.78±0.76 | |||||
对照组 | 189 | 330 | 3.52±1.67 | 54.099±145.69 | 0.22±0.15 | 6.77±3.34 | 3.75±0.78 | |||||
统计值 | 1.917 | 7.735 | 10.126 | 0.806 | 0.140 | 0.670 | ||||||
P值 | 0.166 | <0.001 | <0.001 | 0.420 | 0.889 | 0.503 | ||||||
组别 | 血红蛋白/ (g/L) | 血小板/ (×109/ L) | 淋巴细胞/ (×109/ L) | 单核细胞/ (×109/ L) | 中性粒细胞/(×109/ L) | RDW/% | ||||||
前列腺癌组 | 116.84±23.65 | 194.94±75.12 | 1.36±0.62 | 0.46±0.23 | 4.73±3.17 | 13.80±1.81 | ||||||
对照组 | 115.74±23.92 | 195.80±77.34 | 1.35±0.61 | 0.46±0.23 | 4.77±3.19 | 12.53±0.48 | ||||||
统计值 | 0.734 | 0.180 | 0.355 | 0.153 | 0.192 | 14.998 | ||||||
P值 | 0.463 | 0.857 | 0.723 | 0.879 | 0.848 | <0.001 |
组别 | 例数 | 年龄/岁 | 体质量指数/ (kg/m2) | 糖尿病 | 高血压 | 吸烟史 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
是/例 | 否/例 | 是/例 | 否/例 | 是/例 | 否/例 | |||||||
前列腺癌组 | 497 | 73.03±9.55 | 23.06±2.91 | 47 | 450 | 89 | 408 | 155 | 342 | |||
对照组 | 519 | 72.98±6.63 | 22.95±3.26 | 55 | 464 | 97 | 422 | 176 | 343 | |||
统计值 | 0.099 | 0.605 | 0.366 | 0.104 | 0.858 | |||||||
P值 | 0.921 | 0.546 | 0.545 | 0.747 | 0.354 | |||||||
组别 | 饮酒史 | f-PSA/ (ng/mL) | t-PSA/ (ng/mL) | f-PSA/t-PSA 比值 | 白细胞/ (×109/ L) | 红细胞/ (×1012/ L) | ||||||
是/例 | 否/例 | |||||||||||
前列腺癌组 | 202 | 295 | 49.28±142.38 | 242.15±388.32 | 0.23±0.26 | 6.74±3.32 | 3.78±0.76 | |||||
对照组 | 189 | 330 | 3.52±1.67 | 54.099±145.69 | 0.22±0.15 | 6.77±3.34 | 3.75±0.78 | |||||
统计值 | 1.917 | 7.735 | 10.126 | 0.806 | 0.140 | 0.670 | ||||||
P值 | 0.166 | <0.001 | <0.001 | 0.420 | 0.889 | 0.503 | ||||||
组别 | 血红蛋白/ (g/L) | 血小板/ (×109/ L) | 淋巴细胞/ (×109/ L) | 单核细胞/ (×109/ L) | 中性粒细胞/(×109/ L) | RDW/% | ||||||
前列腺癌组 | 116.84±23.65 | 194.94±75.12 | 1.36±0.62 | 0.46±0.23 | 4.73±3.17 | 13.80±1.81 | ||||||
对照组 | 115.74±23.92 | 195.80±77.34 | 1.35±0.61 | 0.46±0.23 | 4.77±3.19 | 12.53±0.48 | ||||||
统计值 | 0.734 | 0.180 | 0.355 | 0.153 | 0.192 | 14.998 | ||||||
P值 | 0.463 | 0.857 | 0.723 | 0.879 | 0.848 | <0.001 |
组别 | 例数 | <60岁 | 60~69岁 | 70~79岁 | ≥80岁 |
---|---|---|---|---|---|
前列腺癌组 | 497 | 13.87±1.68 | 13.96±1.87 | 13.78±1.96 | 13.70±1.66 |
对照组 | 519 | 13.02±1.25 | 12.49±0.52 | 12.55±0.46 | 12.58±0.42 |
统计值 | 9.119 | 9.016 | 7.723 | 7.902 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | <60岁 | 60~69岁 | 70~79岁 | ≥80岁 |
---|---|---|---|---|---|
前列腺癌组 | 497 | 13.87±1.68 | 13.96±1.87 | 13.78±1.96 | 13.70±1.66 |
对照组 | 519 | 13.02±1.25 | 12.49±0.52 | 12.55±0.46 | 12.58±0.42 |
统计值 | 9.119 | 9.016 | 7.723 | 7.902 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
项目 | B值 | Wald值 | P值 | OR(95%CI) |
---|---|---|---|---|
年龄 | 0.014 | 1.051 | 0.305 | 1.014(0.987~1.041) |
体质量指数 | 0.083 | 4.126 | 0.042 | 1.086(1.003~1.177) |
糖尿病 | 1.281 | 18.398 | 0.778 | 0.677(0.155~1.499) |
高血压 | 0.263 | 1.031 | 0.310 | 0.769(0.463~1.277) |
吸烟史 | 0.008 | 0.469 | 0.498 | 1.008(0.984~1.033) |
饮酒史 | 0.291 | 1.481 | 0.222 | 0.747(0.468~1.193) |
f-PSA | 7.188 | 0.020 | 0.888 | 132.049(0.000~304.6) |
t-PSA | 0.227 | 92.111 | <0.001 | 1.255(1.198~1.315) |
f-PSA/t-PSA比值 | 0.262 | 0.672 | 0.412 | 1.299(0.695~2.429) |
白细胞 | 0.063 | 0.043 | 0.837 | 0.940(0.519~1.699) |
红细胞 | 0.011 | 0.002 | 0.968 | 0.989(0.590~1.659) |
血红蛋白 | 0.002 | 0.061 | 0.805 | 1.002(0.985~1.019) |
血小板 | 0.001 | 0.007 | 0.931 | 1.000(0.998~1.002) |
淋巴细胞 | 0.081 | 0.059 | 0.808 | 1.085(0.563~1.090) |
单核细胞 | 0.059 | 0.015 | 0.903 | 1.061(0.409~2.754) |
中性粒细胞 | 0.059 | 0.039 | 0.844 | 1.061(0.590~1.909) |
RDW | 1.194 | 41.081 | <0.001 | 3.300(2.290~4.753) |
<60岁 | 1.684 | 13.464 | <0.001 | 4.383(1.915~11.633) |
60~69岁 | 1.603 | 19.514 | <0.001 | 4.966(2.439~10.111) |
70~80岁 | 1.049 | 9.657 | <0.001 | 2.856(1.630~5.004) |
≥80岁 | 1.520 | 32.376 | <0.001 | 4.571(2.708~7.715) |
项目 | B值 | Wald值 | P值 | OR(95%CI) |
---|---|---|---|---|
年龄 | 0.014 | 1.051 | 0.305 | 1.014(0.987~1.041) |
体质量指数 | 0.083 | 4.126 | 0.042 | 1.086(1.003~1.177) |
糖尿病 | 1.281 | 18.398 | 0.778 | 0.677(0.155~1.499) |
高血压 | 0.263 | 1.031 | 0.310 | 0.769(0.463~1.277) |
吸烟史 | 0.008 | 0.469 | 0.498 | 1.008(0.984~1.033) |
饮酒史 | 0.291 | 1.481 | 0.222 | 0.747(0.468~1.193) |
f-PSA | 7.188 | 0.020 | 0.888 | 132.049(0.000~304.6) |
t-PSA | 0.227 | 92.111 | <0.001 | 1.255(1.198~1.315) |
f-PSA/t-PSA比值 | 0.262 | 0.672 | 0.412 | 1.299(0.695~2.429) |
白细胞 | 0.063 | 0.043 | 0.837 | 0.940(0.519~1.699) |
红细胞 | 0.011 | 0.002 | 0.968 | 0.989(0.590~1.659) |
血红蛋白 | 0.002 | 0.061 | 0.805 | 1.002(0.985~1.019) |
血小板 | 0.001 | 0.007 | 0.931 | 1.000(0.998~1.002) |
淋巴细胞 | 0.081 | 0.059 | 0.808 | 1.085(0.563~1.090) |
单核细胞 | 0.059 | 0.015 | 0.903 | 1.061(0.409~2.754) |
中性粒细胞 | 0.059 | 0.039 | 0.844 | 1.061(0.590~1.909) |
RDW | 1.194 | 41.081 | <0.001 | 3.300(2.290~4.753) |
<60岁 | 1.684 | 13.464 | <0.001 | 4.383(1.915~11.633) |
60~69岁 | 1.603 | 19.514 | <0.001 | 4.966(2.439~10.111) |
70~80岁 | 1.049 | 9.657 | <0.001 | 2.856(1.630~5.004) |
≥80岁 | 1.520 | 32.376 | <0.001 | 4.571(2.708~7.715) |
项目 | HR(95%CI) | P值 |
---|---|---|
年龄 | 0.402 | |
<73岁 | 1 | |
≥73岁 | 1.841(0.442~7.675) | |
体质量指数 | 0.401 | |
<23.06 kg/m2 | 1 | |
≥23.06 kg/m2 | 0.583(0.165~2.053) | |
吸烟史 | 0.515 | |
否 | 1 | |
是 | 1.575(0.401~6.187) | |
饮酒史 | 0.049 | |
否 | 1 | |
是 | 3.460(1.006~11.907) | |
高血压 | 0.075 | |
否 | 1 | |
是 | 3.744(0.877~15.978) | |
糖尿病 | 0.286 | |
否 | 1 | |
是 | 2.107(0.556~7.319) | |
T 分期 | 0.993 | |
T1~2期 | 1 | |
T3~4期 | 1.008(0.180~5.642) | |
N 分期 | 0.884 | |
N0期 | 1 | |
N1期 | 0.896(0.206~3.897) | |
TNM 分期 | 0.023 | |
Ⅰ~Ⅱ期 | 1 | |
Ⅲ~Ⅳ期 | 3.951(1.209~12.908) | |
治疗方式 | 0.491 | |
根治性前列腺切除术 | 1 | |
雄激素剥夺疗法 | 2.262(0.221~23.129) | |
t-PSA | 0.435 | |
<242.15 ng/mL | 1 | |
>242.15 ng/mL | 0.985(0.947~1.024) | |
RDW | <0.001 | |
<13.8% | 1 | |
≥13.8% | 7.439(4.278~21.088) |
项目 | HR(95%CI) | P值 |
---|---|---|
年龄 | 0.402 | |
<73岁 | 1 | |
≥73岁 | 1.841(0.442~7.675) | |
体质量指数 | 0.401 | |
<23.06 kg/m2 | 1 | |
≥23.06 kg/m2 | 0.583(0.165~2.053) | |
吸烟史 | 0.515 | |
否 | 1 | |
是 | 1.575(0.401~6.187) | |
饮酒史 | 0.049 | |
否 | 1 | |
是 | 3.460(1.006~11.907) | |
高血压 | 0.075 | |
否 | 1 | |
是 | 3.744(0.877~15.978) | |
糖尿病 | 0.286 | |
否 | 1 | |
是 | 2.107(0.556~7.319) | |
T 分期 | 0.993 | |
T1~2期 | 1 | |
T3~4期 | 1.008(0.180~5.642) | |
N 分期 | 0.884 | |
N0期 | 1 | |
N1期 | 0.896(0.206~3.897) | |
TNM 分期 | 0.023 | |
Ⅰ~Ⅱ期 | 1 | |
Ⅲ~Ⅳ期 | 3.951(1.209~12.908) | |
治疗方式 | 0.491 | |
根治性前列腺切除术 | 1 | |
雄激素剥夺疗法 | 2.262(0.221~23.129) | |
t-PSA | 0.435 | |
<242.15 ng/mL | 1 | |
>242.15 ng/mL | 0.985(0.947~1.024) | |
RDW | <0.001 | |
<13.8% | 1 | |
≥13.8% | 7.439(4.278~21.088) |
[1] | 刘大可, 王洁, 冯国杉, 等. 上海市长宁区1973—2013年前列腺癌发病率和死亡率趋势分析[J]. 复旦学报(医学版), 2020,47(6):809-815. |
[2] |
ZAORSKY N G, CHURILLA T M, EGLESTON B L, et al. Causes of death among cancer patients[J]. Ann Oncol, 2017,28(2):400-407.
DOI URL |
[3] | 张华, 张彬, 高留伟, 等. 术前红细胞分布宽度对非小细胞肺癌患者预后的评估价值[J]. 中国肿瘤临床, 2018,45(13):682-686. |
[4] | 丁宁, 陈长强, 樊绮诗. 红细胞分布宽度、血清总胆红素与冠心病及冠状动脉病变程度相关性研究[J]. 检验医学, 2019,34(10):889-893. |
[5] |
TONELLI M, SACKS F, ARNOLD M, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease[J]. Circulation, 2008,117(2):163-168.
DOI URL |
[6] | 杨滇宇, 权文强, 孙祖俊, 等. RDW在恶性肿瘤诊疗中的最新应用[J]. 检验医学, 2018,33(9):844-849. |
[7] | 李毓, 李园, 马硝惟, 等. 红细胞分布宽度标准差评估上皮性卵巢癌预后的意义[J]. 上海医学, 2017,40(10):614-617. |
[8] |
HSUEH C Y, LAU H C, LI S, et al. Pretreatment level of red cell distribution width as a prognostic indicator for survival in a large cohort study of male laryngeal squamous carcinoma[J]. Front Oncol, 2019,9:271.
DOI URL |
[9] | 胡秦, 李纲, 张学锋, 等. 前列腺癌和良性前列腺增生患者红细胞分布宽度的差异[J]. 江苏医药, 2016,42(1):29-31. |
[10] | 周臣, 杨焕, 王军起. 外周血RDW、MPV和血清CEA联合检测对肾细胞癌和肾良性肿瘤的鉴别诊断[J]. 中国临床研究, 2020,33(5):606-610. |
[11] | 梁国刚, 李相峰, 王琳娜, 等. 红细胞分布宽度、C-反应蛋白和癌胚抗原联合检测对结肠癌的诊断价值[J]. 中国卫生检验杂志, 2017,27(11):1569-1570. |
[12] |
CHENG S, HAN F, WANG Y, et al. The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer[J]. BMC Gastroenterol, 2017,17(1):163.
DOI URL |
[13] |
YAZICI P, DEMIR U, BOZKURT E, et al. The role of red cell distribution width in the prognosis of patients with gastric cancer[J]. Cancer Biomark, 2017,18(1):19-25.
DOI URL |
[14] | 张玥, 鞠瑛, 刘义庆, 等. 外周血红细胞体积分布宽度和中性粒细胞计数与淋巴细胞计数比值对前列腺癌的诊断价值[J]. 中国医药, 2018,13(10):1559-1562. |
[15] | 李飞, 钟玉钗, 莫伟平, 等. 红细胞分布宽度对乳腺癌患者总体生存期的预测价值[J]. 广东医学, 2018,39(13):2034-2039. |
[16] |
HAN F, LIU Y, CHENG S, et al. Diagnosis and survival values of neutrophil-lymphocyte ratio(NLR) and red blood cell distribution width(RDW) in esophageal cancer[J]. Clin Chim Acta, 2019,488:150-158.
DOI URL |
[17] |
CHENG S, HAN F, WANG Y, et al. The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer[J]. BMC Gastroenterol, 2017,17(1):163.
DOI URL |
[1] | SUN Chuanyu, ZHAO Xiaojun, GE Shengyang, ZHANG Yang. Transcription factors in prostate cancer progression [J]. Laboratory Medicine, 2023, 38(9): 818-824. |
[2] | WANG Yangshuyi, YE WEI, LIN Zhihao, HUANG Yuenuo, FANG Tao, DONG Xiaoting. Construction and validation of a model for pyroptosis-related features in lung adenocarcinoma [J]. Laboratory Medicine, 2023, 38(9): 833-841. |
[3] | PENG Wei, LI Yungai, XU Jing, LIU Hua, YANG Cuixia, SHEN Yunyue. Serum inflammatory factors combined with PSA and f-PSA in the auxiliary diagnosis of prostate cancer [J]. Laboratory Medicine, 2023, 38(9): 849-854. |
[4] | FU Yi, YANG Xuesong, JIN Ligang, ZHAI Hongli, JIN Xiaoling. Correlation between small and dense low-density lipoprotein cholesterol and acute coronary syndrome with the occurrence of long-term adverse cardiovascular events [J]. Laboratory Medicine, 2023, 38(9): 878-883. |
[5] | ZHANG Han, LI Jun, LIU Xiaojiang, GUAN Yixiang. Role of serum albumin,interleukin-6 and ferritin combined determination in evaluating the functional prognosis of patients with spontaneous intracerebral hemorrhage [J]. Laboratory Medicine, 2023, 38(8): 713-718. |
[6] | ZHANG Na, NIU Weihua, SUN Yuanyuan, JIA Mei. CMV and EBV co-infection affecting patient prognosis after hematopoietic stem cell transplantation [J]. Laboratory Medicine, 2023, 38(8): 760-765. |
[7] | SUN Zepeng, WANG Hongbin, WANG Jiandong, SONG Dewei, XIAO Peng. Analysis and progress of peptide and protein biomarker methodology for myocardial injury [J]. Laboratory Medicine, 2023, 38(8): 784-789. |
[8] | GUO Jie, LI Haixia, LI Xiaoyun. Correlation of preoperative RPR in peripheral blood with the prognosis of endometrial carcinoma patients [J]. Laboratory Medicine, 2023, 38(7): 675-679. |
[9] | WANG Tengfei, CHEN Shan, AN Hebing, ZHOU Lei. Expressions and roles of lncRNA CRNDE and miR-384 in peripheral blood of patients with acute leukemia [J]. Laboratory Medicine, 2023, 38(7): 686-691. |
[10] | YIN Ya, PAN Yuan, ZHOU Hongwei, SHEN Wei. Application progress of BNP and NT-proBNP in neonates [J]. Laboratory Medicine, 2023, 38(6): 518-523. |
[11] | ZHANG Min, WANG Binyu, CHI Weiqun, LIU Yu. Research progress of exosomal non-coding RNA as biomarkers for disease diagnosis [J]. Laboratory Medicine, 2023, 38(6): 594-598. |
[12] | ZHAO Jing, WANG Pei, LU Dandan, QI Dandan, LI Xuan. Expression levels of serum miR-4443 and TRAF4 in patients with hemorrhagic stroke [J]. Laboratory Medicine, 2023, 38(5): 413-418. |
[13] | SU Xi, ZHOU Yan, HUANG Jian, GAO Yaoyi, LI Yihao, WANG Beili, PAN Baishen, GUO Wei. Effect of CYP3A4 *1G polymorphism on fentanyl in patients undergoing laparoscopic radical resection of colorectal cancer [J]. Laboratory Medicine, 2023, 38(5): 419-423. |
[14] | GAO Feng. Clinical application of novel tumor biomarkers:prospects and challenges [J]. Laboratory Medicine, 2023, 38(4): 303-306. |
[15] | SONG Shiwei, LI Jingwu, LIN Tao, LIU Zeyu, WANG Zhiqiang, SUN Weidong. Relationship between GPNMB and non-small cell lung cancer immune infiltration and prognosis [J]. Laboratory Medicine, 2023, 38(4): 347-351. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||